Bright News

Mumbai,  November 26, 2025 :   Utkarsh Small Finance Bank Limited (Utkarsh SFBL)  today  announced a strategic partnership with Axis Securities to provide end-to-end trading and investment services for its customers.  This collaboration marks a significant step in expanding the Bank’s capabilities to deliver next-generation financial solutions. This partnership introduces a unique 3-in-1 account, seamlessly integrating a Savings Account with Utkarsh Small Finance Bank and a Demat and Trading Account with Axis Securities.  This offering is designed to provide customers with a convenient and comprehensive platform for banking and investing. Aligned with Utkarsh Small Finance Bank’s strategy to offer a full spectrum of financial services—including savings and current accounts, deposits, loans, insurance, and investment products—the partnership with Axis Securities will enable customers to seamlessly integrate banking and investing through multiple channels suc...

The Initial Public Offering of Sudeep Pharma was subscribed a massive 93.71 times on the final day of bidding. The issue received bids of 99,00,86,575 shares against the offered 1,05,64,926 equity shares, at a price band of ₹563-593, according to the data available on the stock exchanges. Qualified Institutional Buyer Portion and Non-Institutional Investors Portion were subscribed 213.1 times and 116.7 times respectively, whereas Retail Portion was subscribed 15.65 times.  The issue kicked off for subscription on Friday, November 21, 2025 and closed for subscription on  Tuesday, November 25, 2025 . ICICI Securities and IIFL Capital Services Ltd  are the book-running lead manager; and MUFG Intime India Private Limited is the registrar of the offer. Company Information The company is a technology-led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and is dedicated to contributing to the glob...

India’s first ever index fund designed to track the Nifty MidSmallcap 400 Index – a diversified benchmark combining the Nifty Midcap150 and Nifty Smallcap 250 indices. NFO opens on 24th November and closes on  05th December Investment amount starts from INR 100. India,  25 November 2025 :  Navi AMC, a subsidiary of Navi Limited ( formerly Navi Technologies Limited ), announced the launch of the Navi Nifty MidSmallcap 400 Index Fund, an open-ended index fund that seeks to replicate and track the Nifty MidSmallcap 400 Index. The index represents the combined universe of mid-cap and small-cap companies as defined within the broader Nifty 500. The New Fund Offer (NFO) opens on 24th November 2025 and closes on 5th December 2025. Fund & Index Overview The Scheme will replicate the Nifty MidSmallcap 400 Total Return Index, a free-float market capitalization-weighted index comprising 400 companies (150 mid-cap and 250 small-cap stocks). The index is maintained and rebalanced ...

Mumbai,  November 25 :  Sahajanand Medical Technologies has received final approval from the capital markets regulator, Securities and Exchange Board of India (SEBI), for its initial public offering (IPO). The Company had filed its IPO papers with Sebi on July 25, 2025. The IPO consists of an offer-for-sale of shares of up to 27,644,231 Equity Shares of face value of ₹1 each by promoters - Shree Hari Trust, Dhirajkumar Savjibhai Vasoya and Samara Capital Markets Holding Limited. Other investors selling shares are Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding B V. Incorporated in 2001, the company is a Class III and Class C/D medical devices company with a portfolio of technologically advanced medical devices across vascular and structural heart intervention. According to F&S Report, the company was the first player globally to receive a CE certification for a DES with a biodegradable polymer (Infinnium). Over the years, the company has introduced innovative pr...

The Initial Public Offering of Sudeep Pharma Limited was subscribed 5.09 times on the second day of bidding, demonstrating strong demand from retail and non-institutional investors for this IPO. The issue received bids of 5,38,15,050 against the offered 1,05,64,926 equity shares, according to data available on the stock exchanges. Retail Portion and Non-institutional portion were subscribed 4.97 and 12 times respectively. Qualified Institutional Investors was subscribed 0.13 times. The issue kicked off for subscription on Friday, November 21, 2025 and will close for subscription on  Tuesday, November 25, 2025 . A day before the opening of the issue, Sudeep Pharma Limited had raised Rs 268.5 crore from anchor investors. Leading investors like Mukul Agarwal of Param Capital (Sanshi Fund-I), Prashant Khemka of Whiteoak, Akash Bhansali of ENAM and Prashant Jain from 3P Investment were also a part of the Anchor book.   Leading brokerage firms like Marwadi Financial Services an...